PPL vs STRO
PPL Corporation (PPL) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PPL currently screens at market cap $26.58B and trailing P/E 21.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PPL and STRO stock pages for the full models.
Not investment advice.